Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Huillard

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]E Xylinas, O Huillard, M Peyromaure, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2016
Benefit of therapeutic drug monitoring to disclose pharmacokinetic interaction between sunitinib and calcium channel blockerF Da Silva, A Thomas-Schoemann, O Huillard, et al.
L'Encephale|November 21, 2021
Medical students and the response to COVID-19: Educational preparedness and psychological impact of their involvement in communicating with patients' relativesS Tebeka, O Huillard, B Pignon, et al.
Breast Cancer Research and Treatment|April 24, 2016
Bi-weekly very-high-dose lapatinib: an easy-to-use active option in HER-2-positive breast cancer patients with meningeal carcinomatosisP Lavaud, B Rousseau, Z Ajgal, et al.
British Journal of Cancer|March 7, 2013
Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patientsO Huillard, O Mir, M Peyromaure, et al.
Cancer Chemotherapy and Pharmacology|May 17, 2017
Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicityM Bretagne, A Jouinot, J P Durand, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 3, 2019
[Multidisciplinary and systematic preoperatory-assessment in geriatric urologic oncology surgery: Feasibility and results]L Prin-Touvron, O Huillard, E Xylinas, et al.
European Journal of Cancer (Oxford, England : 1990)|December 28, 2016
Relation between plasma trough concentration of abiraterone and prostate-specific antigen response in metastatic castration-resistant prostate cancer patientsE Carton, G Noe, O Huillard, et al.
British Journal of Clinical Pharmacology|February 1, 2019
Determinants of the interindividual variability in serum cytidine deaminase activity of patients with solid tumoursR Cohen, L H Preta, V Joste, et al.
Investigational New Drugs|October 26, 2014
Role of the lean body mass and of pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of sunitinib in cancer patientsC Narjoz, A Cessot, A Thomas-Schoemann, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]E Xylinas, O Huillard, M Peyromaure, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2016
Benefit of therapeutic drug monitoring to disclose pharmacokinetic interaction between sunitinib and calcium channel blockerF Da Silva, A Thomas-Schoemann, O Huillard, et al.
L'Encephale|November 21, 2021
Medical students and the response to COVID-19: Educational preparedness and psychological impact of their involvement in communicating with patients' relativesS Tebeka, O Huillard, B Pignon, et al.
Breast Cancer Research and Treatment|April 24, 2016
Bi-weekly very-high-dose lapatinib: an easy-to-use active option in HER-2-positive breast cancer patients with meningeal carcinomatosisP Lavaud, B Rousseau, Z Ajgal, et al.
British Journal of Cancer|March 7, 2013
Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patientsO Huillard, O Mir, M Peyromaure, et al.
Cancer Chemotherapy and Pharmacology|May 17, 2017
Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicityM Bretagne, A Jouinot, J P Durand, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 3, 2019
[Multidisciplinary and systematic preoperatory-assessment in geriatric urologic oncology surgery: Feasibility and results]L Prin-Touvron, O Huillard, E Xylinas, et al.
European Journal of Cancer (Oxford, England : 1990)|December 28, 2016
Relation between plasma trough concentration of abiraterone and prostate-specific antigen response in metastatic castration-resistant prostate cancer patientsE Carton, G Noe, O Huillard, et al.
British Journal of Clinical Pharmacology|February 1, 2019
Determinants of the interindividual variability in serum cytidine deaminase activity of patients with solid tumoursR Cohen, L H Preta, V Joste, et al.
Investigational New Drugs|October 26, 2014
Role of the lean body mass and of pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of sunitinib in cancer patientsC Narjoz, A Cessot, A Thomas-Schoemann, et al.
Pageof 1